Skip to main content

Advertisement

SpringerLink
Log in

Resveratrol Attenuates the Blood-Brain Barrier Dysfunction by Regulation of the MMP-9/TIMP-1 Balance after Cerebral Ischemia Reperfusion in Rats

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The collapse of the blood-brain barrier (BBB) is one of the fundamental pathophysiology changes during cerebral ischemia reperfusion injury. Resveratrol has been recently reported to reduce cerebral ischemic damage by regulating the matrix metalloproteinase-9 (MMP-9). But, more direct evidence for the explanation of the BBB protected by resveratrol against cerebral ischemia reperfusion is still lacking. Therefore, the present study was aimed to investigate the regulation of BBB integrity by resveratrol after cerebral ischemia reperfusion and to determine the role of the MMP-9 and its endogenous inhibitor TIMP-1 balance in this process. Cerebral ischemia was induced by middle cerebral artery occlusion in rats. The BBB function was evaluated by brain water content and the Evans blue dye extravasation; the activities of MMP-9 and TIMP-1 were detected by using gelatin zymography analysis, and cellular apoptosis was examined by TUNEL staining. We confirmed that resveratrol reduced the cerebral ischemia reperfusion damage, brain edema, and Evans blue dye extravasation. Moreover, we found that resveratrol improved the balance of MMP-9/TIMP-1 in terms of their expressions and activities. A TIMP-1 neutralizing antibody reversed those neuroprotective effects of resveratrol. In conclusion, resveratrol attenuated the cerebral ischemia by maintaining the integrity of BBB via regulation of MMP-9 and TIMP-1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7(1):41–53

    Article  CAS  PubMed  Google Scholar 

  • Asahi M, Asahi K, Jung JC, Del ZG, Fini ME, Lo EH (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20(12):1681–1689

    Article  CAS  PubMed  Google Scholar 

  • Ashwal S, Tone B, Tian HR, Cole DJ, Pearce WJ (1998) Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 29(5):1037–1046, 1047

    Article  CAS  PubMed  Google Scholar 

  • Belayev L, Busto R, Ikeda M, Rubin LL, Kajiwara A, Morgan L, Ginsberg MD (1998) Protection against blood–brain barrier disruption in focal cerebral ischemia by the type IV phosphodiesterase inhibitor BBB022: a quantitative study. Brain Res 787(2):277–285

    Article  CAS  PubMed  Google Scholar 

  • Belayev L, Busto R, Zhao W, Fernandez G, Ginsberg MD (1999) Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation. Brain Res 833(2):181–190

    Article  CAS  PubMed  Google Scholar 

  • Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477(1–2):267–283

    Article  CAS  PubMed  Google Scholar 

  • Chen HY, Chen TY, Lee MY, Chen ST, Hsu YS, Kuo YL, Chang GL, Wu TS, Lee EJ (2006) Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res 41(2):175–182

    Article  PubMed  Google Scholar 

  • Chen F, Radisky ES, Das P, Batra J, Hata T, Hori T, Baine AM, Gardner L, Yue MY, Bu G, Del ZG, Patel TC, Nguyen JH (2013) TIMP-1 attenuates blood-brain barrier permeability in mice with acute liver failure. J Cereb Blood Flow Metab 33(7):1041–1049

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cheng G, Zhang X, Gao D, Jiang X, Dong W (2009) Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Neurosci Lett 451(2):105–108

    Article  CAS  PubMed  Google Scholar 

  • Desilles JP, Rouchaud A, Labreuche J, Meseguer E, Laissy JP, Serfaty JM, Lapergue B, Klein IF, Guidoux C, Cabrejo L, Sirimarco G, Lavallee PC, Schouman-Claeys E, Amarenco P, Mazighi M (2013) Blood-brain barrier disruption is associated with increased mortality after endovascular therapy. Neurology 80(9):844–851

    Article  PubMed  Google Scholar 

  • Dong W, Gao D, Lin H, Zhang X, Li N, Li F (2008) New insights into mechanism for the effect of resveratrol preconditioning against cerebral ischemic stroke: Possible role of matrix metalloprotease-9. Med Hypotheses 70(1):52–55

    Article  CAS  PubMed  Google Scholar 

  • Dziembowska M, Wlodarczyk J (2012) MMP9: a novel function in synaptic plasticity. Int J Biochem Cell Biol 44(5):709–713

    Article  CAS  PubMed  Google Scholar 

  • Fujimoto M, Takagi Y, Aoki T, Hayase M, Marumo T, Gomi M, Nishimura M, Kataoka H, Hashimoto N, Nozaki K (2008) Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. J Cereb Blood Flow Metab 28(10):1674–1685

    Article  CAS  PubMed  Google Scholar 

  • Garcia JH, Wagner S, Liu KF, Hu XJ (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. statistical validation. Stroke 26(4):627–634, 635

    Article  CAS  PubMed  Google Scholar 

  • Hao HD, He LR (2004) Mechanisms of cardiovascular protection by resveratrol. J Med Food 7(3):290–298

    Article  CAS  PubMed  Google Scholar 

  • Ichiyama T, Kajimoto M, Suenaga N, Maeba S, Matsubara T, Furukawa S (2006) Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis. J Neuroimmunol 172(1–2):182–186

    Article  CAS  PubMed  Google Scholar 

  • Khan M, Dhammu TS, Sakakima H, Shunmugavel A, Gilg AG, Singh AK, Singh I (2012) The inhibitory effect of S-nitrosoglutathione on blood–brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke. J Neurochem 123(Suppl 2):86–97

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lee H, Park JW, Kim SP, Lo EH, Lee SR (2009) Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia. Neurobiol Dis 34(2):189–198

    Article  CAS  PubMed  Google Scholar 

  • Lin YL, Chang HC, Chen TL, Chang JH, Chiu WT, Lin JW, Chen RM (2010) Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J Nutr 140(12):2187–2192

    Article  CAS  PubMed  Google Scholar 

  • Malemud CJ (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11:1696–1701

    Article  CAS  PubMed  Google Scholar 

  • Marchal J, Pifferi F, Aujard F (2013) Resveratrol in mammals: effects on aging biomarkers, age-related diseases, and life span. Ann N Y Acad Sci 1290(1):67–73

    Article  CAS  PubMed  Google Scholar 

  • Olas B, Saluk-Juszczak J, Wachowicz B (2008) D-glucaro 1,4-lactone and resveratrol as antioxidants in blood platelets. Cell Biol Toxicol 24(2):189–199

    Article  CAS  PubMed  Google Scholar 

  • Rahal K, Schmiedlin-Ren P, Adler J, Dhanani M, Sultani V, Rittershaus AC, Reingold L, Zhu J, McKenna BJ, Christman GM, Zimmermann EM (2012) Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn’s disease. Inflamm Bowel Dis 18(4):613–623

    Article  PubMed Central  PubMed  Google Scholar 

  • Raval AP, Lin HW, Dave KR, Defazio RA, Della MD, Kim EJ, Perez-Pinzon MA (2008) Resveratrol and ischemic preconditioning in the brain. Curr Med Chem 15(15):1545–1551

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg GA (2002) Matrix metalloproteinases in neuroinflammation. Glia 39(3):279–291

    Article  PubMed  Google Scholar 

  • Rosenberg GA, Estrada EY, Dencoff JE (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29(10):2189–2195

    Article  CAS  PubMed  Google Scholar 

  • Saha A, Sarkar C, Singh SP, Zhang Z, Munasinghe J, Peng S, Chandra G, Kong E, Mukherjee AB (2012) The blood-brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol. Hum Mol Genet 21(10):2233–2244

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sakata Y, Zhuang H, Kwansa H, Koehler RC, Dore S (2010) Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 224(1):325–329

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Shao AW, Wu HJ, Chen S, Ammar AB, Zhang JM, Hong Y. (2013) Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-kappaB-dependent inflammatory/MMP-9 pathway. CNS Neurosci Ther

  • Siflinger-Birnboim A, Del VP, Cooper JA, Blumenstock FA, Shepard JM, Malik AB (1987) Molecular sieving characteristics of the cultured endothelial monolayer. J Cell Physiol 132(1):111–117

    Article  CAS  PubMed  Google Scholar 

  • Souvenir R, Fathali N, Ostrowski RP, Lekic T, Zhang JH, Tang J (2011) Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia. Neurobiol Dis 44(1):28–37

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Stetler-Stevenson WG (2008) Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal 1(27):e6

    Article  Google Scholar 

  • Tan HK, Heywood D, Ralph GS, Bienemann A, Baker AH, Uney JB (2003) Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Mol Cell Neurosci 22(1):98–106

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Barone FC, White RF, Feuerstein GZ (1998) Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke. Stroke 29(2):516–520

    Article  CAS  PubMed  Google Scholar 

  • Woo MS, Park JS, Choi IY, Kim WK, Kim HS (2008) Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia. J Neurochem 106(2):770–780

    Article  CAS  PubMed  Google Scholar 

  • Xiong L, Zheng Y, Wu M, Hou L, Zhu Z, Zhang X, Lu Z (2003) Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 96(1):233–237

    CAS  PubMed  Google Scholar 

  • Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57(2):178–201

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (Grant No. 43411C1071), the Changjiang Scholars and Innovative Research Team in University (Grant IRT1053), and the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (Grant 2012BA111B02). The authors greatly appreciate the help provided by Miss Yaoying Yu and thank Dr. Bairen Wang for carefully reading the manuscript.

Author information

Authors and Affiliations

  1. Department of Anesthesiology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710004, China

    Haidong Wei, Luming Zhen, Xiaoming Lei, Jianrui Lv & Rongliang Xue

  2. Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi’an, 710032, Shaanxi Province, China

    Shiquan Wang, Qianzi Yang, Zhixin Wu & Lize Xiong

Authors
  1. Haidong Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shiquan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luming Zhen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qianzi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhixin Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaoming Lei
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jianrui Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lize Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rongliang Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Lize Xiong or Rongliang Xue.

Additional information

Drs. Haidong Wei and Shiquan Wang contributed equally to this work.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

ESM 1

(GIF 121 kb)

High resolution image (TIFF 8354 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wei, H., Wang, S., Zhen, L. et al. Resveratrol Attenuates the Blood-Brain Barrier Dysfunction by Regulation of the MMP-9/TIMP-1 Balance after Cerebral Ischemia Reperfusion in Rats. J Mol Neurosci 55, 872–879 (2015). https://doi.org/10.1007/s12031-014-0441-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-014-0441-1

Keywords

Search

Navigation